Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity.

MLA

Xin, Yan-Fei, et al. “Angelica Sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity.” Basic & Clinical Pharmacology & Toxicology, vol. 101, no. 6, Dec. 2007, pp. 421–26. EBSCOhost, https://doi.org/10.1111/j.1742-7843.2007.00144.x.

APA

Xin, Y.-F., Zhou, G.-L., Shen, M., Chen, Y.-X., Liu, S.-P., Chen, G.-C., Chen, H., You, Z.-Q., & Xuan, Y.-X. (2007). Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity. Basic & Clinical Pharmacology & Toxicology, 101(6), 421–426. https://doi.org/10.1111/j.1742-7843.2007.00144.x

Chicago

Xin, Yan-Fei, Guo-Liang Zhou, Min Shen, Yun-Xiang Chen, Shu-Peng Liu, Guo-Chan Chen, Hao Chen, Zhen-Qiang You, and Yao-Xian Xuan. 2007. “Angelica Sinensis: A Novel Adjunct to Prevent Doxorubicin-Induced Chronic Cardiotoxicity.” Basic & Clinical Pharmacology & Toxicology 101 (6): 421–26. doi:10.1111/j.1742-7843.2007.00144.x.